Related Experiment Videos
High-dose interleukin-2 in the therapy of metastatic renal-cell carcinoma
1Investigational Drug Branch, National Cancer Institute, Bethesda, MD 20892.
Seminars in Oncology
|February 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Educating for personalized medicine: a perspective from oncology.
Clinical pharmacology and therapeutics·2009
Anticancer drug discovery and development throughout the world.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002
Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.
Seminars in oncology·2026
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026